Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain

Introduction: We have different treatment alternatives for relapsing-remitting multiple sclerosis–RRMS–within the so-called platform drugs. It would be desirable to know the ideal drug for each patient. Real clinical practice studies provide us with data on drug efficacy in the medium and long term,...

Descripción completa

Detalles Bibliográficos
Autores principales: Landete, Lamberto, Pérez-Miralles, Francisco, García, Sara, Belenguer, Antonio, Gascón, Francisco, Domínguez, Jose Andres, Carcelén-Gadea, María, Quintanilla-Bordás, Carlos, Navarro, Laura, Gabaldón, Laura, Casanova, Bonaventura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603659/
https://www.ncbi.nlm.nih.gov/pubmed/34803877
http://dx.doi.org/10.3389/fneur.2021.727586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603659/
https://www.ncbi.nlm.nih.gov/pubmed/34803877
http://dx.doi.org/10.3389/fneur.2021.727586

Ejemplares similares